Results 91 to 100 of about 206,755 (278)

Transfusion efficacy and influencing factors of patients transfused with different therapeutic doses of platelets: a comparative analysis

Zhongguo shuxue zazhi
[Objective] To compare and analyze the efficacy of platelet transfusion in patients with different doses, and to analyze the risk factors for platelet transfusion refractoriness.
ZHU Jianling, CHENG Tingting, MA Chunya, FU Lihui, SHI Hongmei, YU Yang   +5 more
doaj   +1 more source

From anthelmintic to neuro‐oncology: A systematic review of mebendazole repurposing for brain tumour therapy

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aim Mebendazole (MBZ), a benzimidazole anthelmintic with established clinical use, has emerged as a repurposing candidate for primary brain tumours due to its multimodal anticancer actions and central nervous system penetrance. This systematic review synthesizes preclinical and clinical evidence evaluating MBZ's efficacy, mechanisms of action ...
Ciara B. Blum, Milli McMenamin, Tessa Khoo, John M. Edwin, Prathibha Jose, Liam A. O’Callaghan   +5 more
wiley   +1 more source

Chinese expert consensus on precision diagnosis, treatment, and multidisciplinary management of immune platelet transfusion refractoriness (2026 Edition)

Zhongguo shuxue zazhi
Patients with thrombocytopenia or platelet dysfunction often require platelet transfusions to improve their condition. However, some patients develop platelet transfusion refractoriness (PTR) after multiple transfusions, characterized by a lack of ...
Clinical Transfusion Medicine Professional Committee of the Chinese Society of Blood Transfusion
doaj   +1 more source

Platelet Crossmatch By Flow Cytometry : Evaluation And Feasibility Study [PDF]

, 2015
Pengurusan pesakit yang membentuk kerintangan imun terhadap platelet adalah mencabar. Salah satu kaedah yang ada adalah menerusi pembekalan platelet yang serasi menerusi ujian keserasian platelet.
Yahya, Nurul Munira
core   +1 more source

Harnessing ferroptosis from multilayer defense networks to nanoplatforms for specific cancer therapy

BMEMat, EarlyView.
Nanomaterials target metabolically‐regulated ferroptosis for cancer therapy. Iron‐based or alternative nanoplatforms integrate ferroptosis with chemotherapy, immunotherapy, or radiotherapy. They enable stimulus‐responsive therapies (photothermal, photodynamic, sonodynamic) activated by near‐infrared, light, or ultrasound, achieving potent synergistic ...
Xinyue Xu, Xuejian Wang, Wenyan Jiang, Wan Hairul Anuar Kamaruddin, Chunyan Fang, Pengfei Zhang   +5 more
wiley   +1 more source

The Frequency and Characteristics of the Platelet Refractoriness and Alloimmunization in Platelet Concentrate Multiple-Transfused Thrombocytopenic Patients

, 1999
BACKGROUND: Understanding the cause for platelet refractoriness in a given patient is the critical step in determining the strategy for optimum management. The aim of this study was to establish the causes and frequency of platelet refractoriness as well
용동은, 김현옥, 김현숙
core  

Detection of interictal epileptiform discharges using multiple bilateral insertions of a newly developed microcatheter‐compatible endovascular electroencephalogram electrode: A clinical feasibility trial

Epilepsia Open, EarlyView.
Abstract Objective To assess the feasibility, technical performance, and safety of a novel endovascular electroencephalogram (eEEG) electrode, EP‐01, designed for minimally invasive seizure localization in patients with drug‐resistant epilepsy. Methods This single‐center, prospective, exploratory trial enrolled five patients with drug‐resistant ...
Kota Araki, Yosuke Masuda, Ayataka Fujimoto, Mitsuyo Nishimura, Hisayuki Hosoo, Hiroki Ishida, Takashi Enokizono, Kensuke Kawai, Eiichi Ishikawa, Yuji Matsumaru   +9 more
wiley   +1 more source

Platelet transfusion refractoriness in highly immunized beta thalassemia children undergoing stem cell transplantation

, 2010
Immune-mediated refractoriness to platelet transfusion is a major problem in patients undergoing HSCT. In a cohort of 50 pediatric patients affected by beta thalassemia coming from Middle East countries, we experienced a high incidence of refractoriness ...
Poli F, Cappelli B, Marktel S, Fleischhauer K., Chiesa R, Rossini S, Zino E, Crocchiolo R, Ronchi P, Napolitano S, RONCAROLO , MARIA GRAZIA, CICERI , FABIO   +11 more
core   +1 more source

Reconstructing Skull Base Reconstruction: The State of the Art

Head &Neck, EarlyView.
ABSTRACT Background Skull base reconstruction has continued to evolve in parallel with advances in endoscopic skull base ablation in order to accomplish the goal of restoring larger and more complicated defects between the cranial and nasal cavities while balancing morbidity, cost, and recovery.
Muhammad El Shatanofy, Zoukaa Sargi, Eric Nisenbaum   +2 more
wiley   +1 more source

Evaluation of the provision of crossmatch compatible platelets for haematology patients who have acquired non-immune refractoriness [PDF]

, 2022
Platelet demand is unpredictable and will relate to case mix, programmes of treatment requiring intensive platelet support and health service activity.
Reynolds, Samantha J.
core